Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

RTTNews | 432 days ago
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

(RTTNews) - Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians.

The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve. It will also enable Walgreens to reach more communities faster to provide comprehensive, affordable care that improves long-term health outcomes.

"At Pearl Health, we believe that local primary care providers are key to improving America's overall health. Our technology-powered value-based care model aligns seamlessly with the healthcare services Walgreens offers, particularly in the most vulnerable communities," said Michael Kopko, CEO of Pearl Health.

Pearl Health offers technology and insight solutions that empower clinical teams to provide holistic, personalized treatment necessary for value-based, quality-focused care.

Pearl Health will complement the services provided by Walgreens by providing prescription fulfillment, medication adherence, immunizations, care gap closure and diagnostic testing. Walgreens will also help patients discharged from the hospital in transition to home.

Previously, Walgreens made a major investment of $5.2 billion to increase its stake in primary-care network VillageMD to 63 percent to advance its access to primary care in under-served urban and rural communities.

This will accelerate the opening of at least 600 Village Medical at Walgreens primary care practices in more than 30 U.S. markets by 2025 and 1,000 by 2027.

A year ago, Walgreens acquired the remaining 30 percent stake in privately-held Shields Health Solutions, which is a premier health system-owned specialty pharmacy integrator in the U.S.

In November last year, Walgreens acquired the remaining 45 percent stake CareCentrix to expand its reach into the growing home-care sector and advancing its healthcare long-term growth strategy.

read more
Walgreens To Close 1,200 US Stores

Walgreens To Close 1,200 US Stores

Walgreens announced its plan to close around 1,200 U.S stores over the next three years, including around 500 closures in fiscal 2025, as the drug store chain is facing a challenging U.S. retail environment amid increasing competition. The move, which was announced while reporting a significantly wider net loss in its fourth quarter, is expected to be immediately accretive to adjusted earnings...
RTTNews | 32 days ago
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 258 days ago
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews | 431 days ago
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
RTTNews | 509 days ago
Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. are planning to offer abortion pills after the U.S. Food and Drug Administration decided to allow retail pharmacies to sell the product in the United States, reports said. On Tuesday, the agency announced a regulatory change allowing mifepristone, which is used in first-trimester abortions, to be dispensed by retail pharmacies.
RTTNews | 682 days ago